These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 4274969)

  • 1. Mode of action of a Staphylococcus epidermidis bacteriocin.
    Jetten AM; Vogels GD
    Antimicrob Agents Chemother; 1972 Dec; 2(6):456-63. PubMed ID: 4274969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of staphylococcin 1580 on cells and membrane vesicles of Bacillus subtilis W23.
    Weerkamp A; Vogels GD
    Biochim Biophys Acta; 1978 Mar; 539(3):386-97. PubMed ID: 415763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological activity of staphylococcin 162: bacteriocin from Staphylococcus aureus.
    Hale EM; Hinsdill RD
    Antimicrob Agents Chemother; 1975 Jan; 7(1):74-81. PubMed ID: 1137360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nature and properties of a Staphylococcus epidermidis bacteriocin.
    Jetten AM; Vogels GD
    J Bacteriol; 1972 Oct; 112(1):243-50. PubMed ID: 5079064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of the killing effect of a Staphylococcus epidermidis bacteriocin.
    Jetten AM; Vogels GD
    Antonie Van Leeuwenhoek; 1974; 40(1):177-83. PubMed ID: 4545195
    [No Abstract]   [Full Text] [Related]  

  • 6. Physiological conditions affecting Staphylococcus aureus susceptibility to staphylococcin 1580.
    Weerkamp A; Vogels GD
    Antimicrob Agents Chemother; 1978 Feb; 13(2):146-53. PubMed ID: 25615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Energy requirements for the action of staphylococcin 1580 in Staphyloccus aureus.
    Weerkamp A; Geerts W; Vogels GD
    Biochim Biophys Acta; 1978 Mar; 539(3):372-85. PubMed ID: 204362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production and mode of action of lactocin 27: bacteriocin from a homofermentative Lactobacillus.
    Upreti GC; Hinsdill RD
    Antimicrob Agents Chemother; 1975 Feb; 7(2):139-45. PubMed ID: 1137365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibacterial Activity, Cytotoxicity, and the Mechanism of Action of Bacteriocin from Bacillus subtilis GAS101.
    Sharma G; Dang S; Gupta S; Gabrani R
    Med Princ Pract; 2018; 27(2):186-192. PubMed ID: 29402863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conditional killing effect of staphylococcin 1580 and repair of sublethal injury in Staphylococcus aureus.
    Weerkamp A; Geerts W; Vogels GD
    Antimicrob Agents Chemother; 1977 Sep; 12(3):314-21. PubMed ID: 20837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Butyricin 7423: a bacteriocin produced by Clostridium butyricum NCIB7423.
    Clarke DJ; Morris JG
    J Gen Microbiol; 1976 Jul; 95(1):67-77. PubMed ID: 956780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and mode of action of a staphylococcin-like substance active against gram-positive and gram-negative bacteria.
    Kader OA; Sahl HG; Brandis H
    J Gen Microbiol; 1984 Sep; 130(9):2291-300. PubMed ID: 6389764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mode of action of a bacteriocin from Serratia marcescens.
    Foulds J
    J Bacteriol; 1971 Sep; 107(3):833-9. PubMed ID: 4328755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mode of action of the staphylococcin-like peptide Pep 5 and culture conditions effecting its activity.
    Sahl HG; Brandis H
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jun; 252(2):166-75. PubMed ID: 6181629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical and ultrastructural changes in Staphylococcus aureus treated with staphylococcin 1580.
    Weerkamp A; Heinen-von Borries UT; Vogels GD
    Antonie Van Leeuwenhoek; 1978; 44(1):35-48. PubMed ID: 655698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production and purification of a Staphylococcus epidermidis bacteriocin.
    Jetten AM; Vogels GD; de Windt F
    J Bacteriol; 1972 Oct; 112(1):235-42. PubMed ID: 5079063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a Staphylococcus aureus bacteriocin.
    Gagliano VJ; Hinsdill RD
    J Bacteriol; 1970 Oct; 104(1):117-25. PubMed ID: 5473880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of bacteriocin produced by Lactococcus sp. HY 449 on skin-inflammatory bacteria.
    Oh S; Kim SH; Ko Y; Sim JH; Kim KS; Lee SH; Park S; Kim YJ
    Food Chem Toxicol; 2006 Apr; 44(4):552-9. PubMed ID: 16226831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production and properties of a staphylococcin genetically controlled by the staphylococcal plasmid for exfoliative toxin synthesis.
    Rogolsky M; Wiley BB
    Infect Immun; 1977 Mar; 15(3):726-32. PubMed ID: 870429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification and properties of a bacteriocin of Staphylococcus epidermidis isolated from dental plaque.
    Nakamura T; Hirai K; Shibata Y; Fujimura S
    Oral Microbiol Immunol; 1998 Dec; 13(6):387-9. PubMed ID: 9872117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.